Skip to main content

Client News

Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)

11th March 2019

HPS Home Power Solutions GmbH to present Picea – the all-in-one energy storage system – at upcoming trade fairs

8th March 2019

www.homepowersolutions.de

Apogenix Announces Oral and Poster Presentations at Upcoming International Conferences

7th March 2019

www.apogenix.com

Interim Results for the six months ended 31 December 2018

6th March 2019

www.allergytherapeutics.com

Newron announces 2018 financial results and provides outlook for 2019

5th March 2019

Abivax Chosen to Deliver ABX464 Oral Presentation at Digestive Disease Week (DDW) Conference in the U.S.

5th March 2019

NOXXON to launch NOX-A12 with radiotherapy clinical trial in patients with brain cancer

4th March 2019

Biom’up sees a strong commercial uptake in HEMOBLAST(TM) Bellows in the US and Europe

4th March 2019

Bencard Allergie GmbH: Specialist in allergen-specific immunotherapies addresses new practical recommendations for the treatment of insect venom allergy with introduction of user-friendly pack size for insect venom product

4th March 2019

www.medigene.com

Avisa Reports on Progress with Biomarker AV BreathTest™ Platform

4th March 2019

www.avisapharma.com